In a 6-week, double-blind, randomized, placebo-controlled clinical trial, nearly 3/4 of perimenopausal women who took the Perelel Perimenopause Support Pack experienced clinically meaningful improvements in stress and improved menopausal symptoms.*
Please note that individual results may vary, and that weight loss may not be seen in every person who takes semaglutide
With the advancement of research, the understanding of COPD etiology has expanded from exposure to harmful gases/particles to multiple etiological types. New classifications of COPD have emerged, including the pulmonary cachexia phenotype, COPD-bronchiectasis overlap phenotype, rapid progressive phenotype, non-smoking COPD phenotype, comorbidity/systemic phenotype, upper lobe-predominant emphysema phenotype, 1-antitrypsin deficiency phenotype, and early disease-related phenotypes (pre-COPD, early-onset COPD, preserved ratio impaired lung function) ( In contrast, an endotype represents the underlying biological or molecular mechanisms that produce these observable traits
2025;48(Suppl 1):S86S127
